Comvax

Haemophilus B and hepatitis B vaccine

Haemophilus B and hepatitis B vaccine

Add article description

Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine.[1][2] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B.[2]

Quick Facts Combination of, Hib vaccine ...

A branded formulation, Comvax, was marketed in the US by Merck.[3][4] It was discontinued in 2014.[5]

References

  1. [1]
    "Comvax". Drugs.com. Retrieved 15 July 2018.
  2. [2]
    "Haemophilus b conjugate and hepatitis b vaccine Intramuscular Advanced Patient Information". Drugs.com. 14 February 2020. Retrieved 13 September 2020.
  3. [3]
    Centers for Disease Control and Prevention (February 1997). "FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine" (PDF). MMWR Morb. Mortal. Wkly. Rep. 46 (5): 107–9. PMID 9045037.
  4. [4]
    "Comvax package insert" (PDF). Retrieved 15 July 2018.
  5. [5]
    Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016: 7203587. doi:10.1155/2016/7203587. PMC 4745871. PMID 26904695.
Stub icon

This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Comvax, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.